Recent Publications

• Cortical hem-like progenitors contribute pyramidal neurons to the neocortex and hippocampus.Parichha A, Azzam P, Causeret F, Pal S, Grove EA, Louvi A, Pierani A, Tole S. Dev Biol. 2026 Jun; 2026 Feb 28. PMID: 41771395.
• G-CSF for Mobilizing CD34(+) Cells in Individuals With SCD: A Word of Caution.Sharma A, Abraham A, Bhatia M, Cancio M, Chaudhury S, Corbacioglu S, Guilcher GMT, Gupta AO, Hanna R, Heeney MM, John T, Krishnamurti L, LaBelle JL, Rangarajan HG, Shenoy S, Stenger E, Strunk C, Fitzhugh CD. Am J Hematol. 2026 Jun; 2026 Feb 18. PMID: 41705621.
• Non-invasive profiling of the tumour microenvironment with spatial ecotypes.Zhang W, Brown EL, Usmani A, Earland N, Kang M, Olelewe C, Viswanathan A, Chauhan PS, Steen CB, Jeon HS, Avagyan S, Alahi I, Semenkovich NP, Schwab JC, Sachs CM, Qaium F, Harris PK, Cai Q, Gentles AJ, Knight J, Graham RP, Bacchiocchi A, Lucas PC, Fields RC, Sznol M, Halaban R, Chen DY, Chaudhuri AA, Newman AM. Nature. 2026 May 6; 2026 May 6. PMID: 42092150.
• Ex Vivo Expansion of Melanoma Tumor-Infiltrating Lymphocytes Leads to a Dominant Exhausted T-cell Population with a Lack of Memory Markers.Coppola G, Kerr S, Cha PC, Bersenev A, Olino K, Kluger HM, Sznol M, Weiss SA, Bosenberg MW, Kleinstein SH, Krause DS, Hurwitz ME, Katz SG. Cancer Immunol Res. 2026 May 4. PMID: 41686210.
• Spatially decoding genotype-associated epigenetic landscapes in human lymphoma FFPE tissues via epi-Patho-DBiT.Li H, Tao B, Enninful A, Zhang D, Dai Y, Oh F, Farzad N, Li K, Bai Z, Qin X, Yang M, Hwang EJ, Zhang J, Lu J, Gerstein M, Zhou J, Xu ML, Fan R. Nat Commun. 2026 May 1; 2026 May 1. PMID: 42067542.
• Acute myeloid leukemia after myeloproliferative neoplasms: Real-world outcomes in the new treatment era in the United States.Bewersdorf JP, Wang R, Mendez L, Mina A, Aguirre LE, Stahl M, Zeidan AM, Ma X, Podoltsev NA. Cancer. 2026 May 1. PMID: 42033416.
• Global, regional, and national burden of meningitis, its risk factors, and aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.Lancet Neurol. 2026 May; 2026 Mar 27. PMID: 41911930.
• Clinical strategies for leukemia management: Recommendations from the Bridging the Gaps in Hematology Oncology Consensus Conference 2025.Carraway HE, DeAngelo DJ, Wang ES, Komrokji RS, Perl AE, Zeidan A, Brunner A, Lai C, Park JH, Zeidner JF, Weeks L, Luskin MR, Chandhok NS, Loghavi S. Leuk Res. 2026 May; 2026 Mar 20. PMID: 41895012.
• Impact of age on outcomes after CD19 CAR T-cell therapy for large B-cell lymphomas.Mirza AS, Hosing C, Foss F, Kim S, Moskop A, Oloyede T, Abid MB, Afrough A, Ahmed S, Badar T, Barba P, Bhatt VR, Brown VI, Dahiya S, Deol A, Epperla N, Ganguly S, Grover NS, Hashmi H, Hashmi S, Hematti P, Hildebrandt GC, Hill JM Jr, Hossain NM, Ibrahim U, Johnson PC, Kharfan-Dabaja MA, Krem MM, Lekakis LJ, Maziarz RT, Murthy HS, Riedell PA, Salas MQ, Shouse G, Strouse C, Thakar MS, Turtle CJ, Woolfrey A, Wudhikarn K, Yared JA, Pasquini MC, Gowda L. Blood Neoplasia. 2026 May; 2025 Nov 25. PMID: 41867486.
• Comparative effectiveness of HMA with venetoclax vs intensive chemotherapy in AML with very high-risk cytogenetics.Aguirre LE, Bewersdorf JP, Liu Y, Shallis RM, Boussi L, Zucenka A, Garciaz S, Bystrom RP, DeAngelo DJ, Stone RM, Luskin MR, Garcia JS, Winer ES, Ling K, Chen EC, Wadleigh M, Berton G, Stein EM, Goldberg AD, Mendez L, Zeidan AM, Sallman DA, Shimony S, Stahl M. Blood Neoplasia. 2026 May; 2026 Jan 28. PMID: 41859348.
• Epigenetic activation of EBV BGLF4 determines antiviral-based regimen response in EBV+CNS lymphoproliferative disease.Weigel C, Klimaszewski HL, Tounkara F, Addissie S, Schlotter S, Pray B, Dugan JP, Haverkos BM, Villagomez L, Lustberg M, Porcu P, Voorhees T, Ambinder RF, Kenney SC, Fingeroth J, Delecluse HJ, Caligiuri MA, Alinari L, Bumgardner G, Oakes CC, Baiocchi RA. Blood Neoplasia. 2026 May; 2026 Jan 28. PMID: 41808730.
• Emerging biomarkers in melanoma: Bridging molecular discovery and precision oncology.Xu S, Huang Z, Li Y, Lu L, Ma W. Cancer Lett. 2026 May 1; 2026 Feb 22. PMID: 41734832.
• Baseline IPSS-M vs pretransplant risk downstaging as prognostic determinants in MDS undergoing allogeneic transplantation.Aguirre LE, Kim HT, Elmariah H, Frumm SM, Kelkar AH, Ho V, Gooptu M, Koreth J, Shapiro RM, Romee R, Nikiforow S, Antin JH, Soiffer RJ, Shimony S, Luskin MR, Garcia JS, Chen EC, Wadleigh M, Winer ES, Stone RM, DeAngelo DJ, Al Ali N, Sallman D, Kuykendall A, Sweet K, Lancet JE, Padron E, Chan O, Xie Z, Cutler CS, Komrokji RS, Stahl M. Blood Adv. 2026 Apr 28. PMID: 41587470.
• Understanding the impact of social determinants of health in hematology: a scoping review of trends across journals and over time.Lu B, Troyer J, Krause KJ, Lapite A, Aviles M, Della-Moretta S, Dobson D, Farrokhi K, Hasanali ZS, Pillai P, Taborda C, Villagomez L, Vo PT, Wang'ondu RW, Yui JC, Weyand AC, Fingrut WB. Blood Adv. 2026 Apr 28. PMID: 41587417.
• Spatial predictors of response to chemo-immunotherapy in microsatellite stable metastatic colorectal cancer.Choo J, Zhao JJ, Lau MC, Raimondi A, Yim WW, Ranganathan S, Zhu K, Tan CTY, Chin HX, Teo CB, Fong KY, Tay RYK, Lee JJ, Loo LH, Manca P, Morano F, Prisciandaro M, Randon G, Damonte C, Micarelli E, Leoni G, Scarselli E, Lonardi S, Cremolini C, Marmorino F, Lim JCT, Neo ZW, Wee F, Chong LY, Joseph CR, Balachander A, Lim DG, Hwang YY, Renia L, Biswas SK, Tan D, Yeong JPS, Sundar R, Pietrantonio F. Nat Commun. 2026 Apr 25; 2026 Apr 25. PMID: 42034603.
• Transcriptomic and phenotypic convergence of neurodevelopmental disorder risk genes in vitro and in vivo.Fernandez Garcia M, Retallick-Townsley K, Pruitt A, Davidson EA, Balafkan N, Warrell J, Huang TC, Kibowen A, Chu Z, Dai Y, Fitzpatrick SE, Meng R, Sen A, Cohen S, Livoti O, Khan S, Becker C, Luiz Teles E Silva A, Liu J, Dossou G, Cheung J, Liu S, Ghorbani S, Deans PJM, DeCiucis M, Emani P, Gao H, Shen H, Gerstein M, Wang Z, Huckins LM, Hoffman EJ, Brennand K. Nat Neurosci. 2026 Apr 24; 2026 Apr 24. PMID: 42032432.
• Mosaic integration of spatial multi-omics with SpaMosaic.Yan X, Fang Z, Ang KS, Olst LV, Edwards A, Watson T, Zheng R, Zhang D, Fan R, Li M, Gate D, Chen J. Nat Genet. 2026 Apr 24; 2026 Apr 24. PMID: 42032296.
• The Pivotal Roles of Macrophages and Microglia in Mesenchymal Stromal/Stem Cell-Derived Small Extracellular Vesicle-Mediated Tissue Repair After Spinal Cord Injury.Nakazaki M, Lankford KL, Yokoyama T, Ukai R, Hirota R, Oka S, Sasaki M, Kocsis JD, Honmou O. Front Biosci (Landmark Ed). 2026 Apr 23. PMID: 42052826.
• Shear Preconditioning Restores Endothelial Function of HLHS Patient-Derived iPSC-ECs for Successful Conduit Implantation.Zhang W, Qin L, Fooldia S, Ménoret S, Johns A, Anegon I, Nelson TJ, Tellides G, Qyang Y. Arterioscler Thromb Vasc Biol. 2026 Apr 23; 2026 Apr 23. PMID: 42021735.
• Nanotherapeutic Strategies for Osteoarthritis: Targeting Aging, Metabolism and Inflammation.He Z, Chen Y, Zhao K, Jiao Y, Ji Y, Mao D, Wan R, Zhang J, Hu Y. Int J Nanomedicine. 2026; 2026 Apr 22. PMID: 42046738.
• Advances in stem cell-based tissue-engineered skin substitutes for burns.Chogan F, Chen Y, Maneyapanda E, Simmons CA, Santerre JP, Haykal S, Jeschke MG. Trends Biotechnol. 2026 Apr 22; 2026 Apr 22. PMID: 42025530.
• Reference-free discovery with barcoded single-cell sequencing.Dehghannasiri R, Kokot M, Starr AL, Maziarz J, Gordon T, Tan SY, Wang PL, Voskoboynik A, Musser JM, Deorowicz S, Salzman J. Nat Biotechnol. 2026 Apr 22; 2026 Apr 22. PMID: 42020848.
• Endothelial MHC expression is required to initiate T cell-mediated rejection of 3D-printed skin grafts.Tobiasova Z, Sefik E, Qin L, McNiff JM, Davis G, Flavell RA, Saltzman WM, Pober JS. JCI Insight. 2026 Apr 22; 2026 Apr 22. PMID: 42018655.
• TRPM7 Deficiency Protects Against Myocardial Ischemia-Reperfusion Injury by Regulating Intracellular Zn(2+) Homeostasis.Li X, Li X, Li CX, Feng J, Yue Z, Yan J, Matsushita M, Qyang Y, Runnels LW, Ai X, Yue L. Circulation. 2026 Apr 21; 2026 Feb 6. PMID: 41645903.
• Organ injury in systemic autoimmunity is mediated by stem-like CD8(+) T cells arising from tissue-draining lymph nodes.Al Souz J, Wei Y, Cui C, Qu R, Choi JY, Wang F, Moioffer SJ, Barrett J, Chernova I, Nadella M, Siniscalco ER, Moeckel G, Joshi NS, Chen PM, Arazi A, Ho YC, Craft J. Immunity. 2026 Apr 20; 2026 Apr 20. PMID: 42013863.
• Single-cell omics uncovers novel pathological mechanisms and therapeutic targets for congenital heart diseases: insights from integrated intercellular communication analysis.Nguyen PT, Sahara M. Stem Cell Res Ther. 2026 Apr 16; 2026 Apr 16. PMID: 41992274.
• B lymphocyte protein factories produced by hematopoietic stem cell gene editing.Hartweger H, Ruprecht C, Yao KH, Laffont P, Lima Dos Reis G, Zhou P, Hägglöf T, Binet L, Loewe M, Hong JP, Xiao T, Sefik E, Hernandez B, Gazumyan A, Jankovic M, Seaman MS, Costa G, Nelson SA, Clark J, Kanatani S, Wilson PC, Krammer F, Levashina EA, Julien JP, Wardemann H, Sinnis P, Stamatatos L, Flavell RA, Nussenzweig MC. Science. 2026 Apr 16; 2026 Apr 16. PMID: 41990179.
• Pridopidine Protects ALS Patient-Derived Neural Progenitor Cells via Sigma-1 Receptor Activation.Meltzer M, Zamir MS, Tzuri N, Tan AM, Geva M, Hayden MR, Lichtenstein RG. Int J Mol Sci. 2026 Apr 14; 2026 Apr 14. PMID: 42074133.
• A 2026 update on myelodysplastic neoplasms: current state, challenges and future directions.Bewersdorf JP, Mina A, Stahl M, Zeidan AM. Nat Rev Clin Oncol. 2026 Apr 14; 2026 Apr 14. PMID: 41981151.
• R-loop landscapes in the developing human brain are linked to neural differentiation and cell type-specific transcription.LaMarca EA, Saito A, Plaza-Jennings A, Espeso-Gil S, Hellmich A, Fernando MB, Javidfar B, Liao W, Estill M, Townsley K, Florio A, Ethridge JE, Do C, Tycko B, Shen L, Kamiya A, Tsankova NM, Brennand KJ, Akbarian S. Transl Psychiatry. 2026 Apr 13; 2026 Apr 13. PMID: 41974678.
• Fertilization with Protamine-2 deficient sperm triggers abnormal pronucleus development and zygotic cleavage†.Rainsford SR, Tse K, Walters BW, Oh JN, Sumigray K, Lesch BJ, Smith ZD. Biol Reprod. 2026 Apr 13. PMID: 41556312.
• Fibroblast depletion reveals mammalian epithelial resilience across neonatal and adult stages.Gaeta IM, Du S, Villeneuve C, Gonzalez DG, Matte-Martone C, Ganesan S, Simpson D, Tibebu H, Moore JL, Kam CY, Gallini S, Wei H, Bertillot F, Zeuschner D, Gonzalez LE, Rana U, Sumigray KD, Wickström SA, Greco V. bioRxiv. 2026 Apr 11; 2026 Apr 11. PMID: 40766486.
• Dysregulation of Hippo Signaling Pathway as a Convergent Mechanism Underlying Choroid Plexus Defects in Bipolar Disorder.Kim J, Choe MS, Kaya K, Hu Y, Ng KK, Qiu C, Zhong M, Yang WS, Kiral FR, Lo C, Scandura M, Cha HJ, Gruen JR, Lek M, Jonas EA, Blumberg HP, Park IH. bioRxiv. 2026 Apr 10; 2026 Apr 10. PMID: 41993308.
• ERK-Mediated Phosphorylation of YAP Defines a Noncanonical FGF Signaling Mechanism in Stem Cells.Zhao X, Erhardt S, Tang L, Chen X, Farmer SM, Cheng Z, Chen W, Lu EZ, Sung K, Tsai CR, Zheng M, Zhang S, Liu Y, Wang J, Li M, Martin JF, Wang J. Adv Sci (Weinh). 2026 Apr 10; 2026 Apr 10. PMID: 41961483.
• Locat: Joint enrichment and depletion testing identifies localized marker genes in single-cell transcriptomics.Lewis W, Aizenbud Y, Strino F, Kluger Y, Parisi F. bioRxiv. 2026 Apr 9; 2026 Apr 9. PMID: 41993378.
• Predictors of complete molecular response and impact of allogeneic hematopoietic stem cell transplantation on outcome in patients with Philadelphia chromosome positive acute lymphoblastic leukemia (ALL): results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND).Mohty R, Narra R, Mims AS, Hunter C, Shallis RM, Kota V, Jamy O, Coltoff A, Othman TA, Jonas BA, Patel AA, DuVall AS, Foucar CE, Abdelsamia M, Palmisiano N, Patel SA, Curran E, Omer Z, Advani A, Atallah E, Litzow MR, Badar T. Leuk Lymphoma. 2026 Apr 9; 2026 Apr 9. PMID: 41954351.
• AT2-intrinsic Z-AAT expression drives conserved inflammatory and proteotoxic stress responses and predisposes to emphysema.Merritt C, Griffin RP, Abo KM, Kaserman JE, Bawa PS, Martin CV, Wang F, Morley M, Cho M, Basil MC, Sauler M, Wilson AA. bioRxiv. 2026 Apr 8; 2026 Apr 8. PMID: 41993529.
• RPS19 and RPL5 haploinsufficient models reveal divergent ribosomal subunit controls of fetal hematopoiesis.Tang Y, Ling T, Mehmood R, Bertrand A, Papoin J, Khan M, Rao R, Xu J, Schulz V, Palis J, Steiner LA, Barnes BJ, Zou YR, Marambaud P, Signer RAJ, Roberts I, Iskander D, Zon LI, Bhoopalan SV, Weiss MJ, Lipton JM, Gallagher PG, Mohandas N, Taylor N, Durand S, Crispino J, Blanc L. Nat Commun. 2026 Apr 8; 2026 Apr 8. PMID: 41951665.
• Molecular and Mechanistic Divergence of Seizures in Pediatric Acute Lymphoblastic Leukemia: CNS Infiltration Versus Chemotherapy-Induced Neurotoxicity.Joo J, Yang WS, Koh HJ. Int J Mol Sci. 2026 Apr 6; 2026 Apr 6. PMID: 41977486.
• PCSK9 promotes prostate cancer via facilitating intratumoral cholesterol accumulation and enhancing immunosuppressive tumor microenvironment.Gu Y, Wei F, Dong Y, Lin X, Su Y, Wood G, Seidah NG, Bonert M, Werstuck G, Aziz T, Major P, Tang D. J Adv Res. 2026 Apr 6; 2026 Apr 6. PMID: 41951051.
• Drift of positional identity drives reproductive aging in a long-lived regenerative animal.Verdesca A, Poulet A, Bales M, van Wolfswinkel JC. Curr Biol. 2026 Apr 6; 2026 Mar 23. PMID: 41875878.
• Mind the Gap: eGFR Discordancy and Melphalan Toxicity in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant.Aklilu AM, Shirali AC. Kidney360. 2026 Apr 1; 2026 Apr 30. PMID: 42060478.
• A guide to using embedded ethics in human stem-cell-based embryo model research.Bentzen HB, Gaillard M, Nachman I, Reumann D, Gadegaard N, David L, Lanner F, Moris N, Pasque V, Rivron N, Sozen B, Isasi R, Krauss S, Veenvliet JV. Nat Cell Biol. 2026 Apr; 2026 Apr 8. PMID: 41951755.
• Irisin ameliorates obesity and insulin resistance via adipose tissue IL-33 and regulatory T cells.A M, Wang G, Zammit NW, Roth L, Maierhaba Y, Bogoslavski D, Cai C, Langston PK, Zhang Q, Afonina IS, Beyaert R, Spiegelman BM, Mathis D. Nat Metab. 2026 Apr; 2026 Apr 3. PMID: 41933175.
• NeMO Analytics: a compendium of transcriptomic data for the exploration of neocortical development.Sonthalia S, Herb B, Adkins RS, Orvis J, Li G, Liao X, Yu Q, Blanco XM, Casella A, Liu J, Stein-O'Brien G, Caffo B, Hertzano R, Mahurkar A, Xu JC, Gillis J, Werner J, Ma S, Kim SK, Micali N, Sestan N, Rakic P, Santpere G, Ament SA, Colantuoni C. Nat Neurosci. 2026 Apr; 2026 Mar 25. PMID: 41882195.
• OR7A10 GPCR engineering boosts CAR-NK therapy against solid tumours.Yang L, Renauer PA, Tang K, Saskin J, Zhou L, Zou C, Lee SH, Fox M, Johnson-Noya S, Weiss B, Deng S, Fang P, Chen B, Sferruzza G, Fooladi S, Zhao K, Park D, Zhang F, Tu J, Chen J, Moliterno J, Gunel M, Peng L, Chen S. Nature. 2026 Apr; 2026 Feb 25. PMID: 41741641.
• Advancing substance use disorder biology by studying underlying gene x environment interactions.Sidamon-Eristoff AE, Rivera-Hernandez M, Huckins LM, Montalvo-Ortiz JL, Brennand KJ. Curr Opin Genet Dev. 2026 Apr; 2026 Feb 16. PMID: 41702263.
• RBC Alloimmunization Impacts Pediatric Sickle Cell Disease Transplant Outcomes and Transfusion Burden: A STAR Registry Report.Inam Z, Stenger E, John TD, Liu K, Gillespie S, Shah R, Chellapandian D, Bhatia M, Chaudhury S, Eckrich MJ, Guilcher GMT, Hendrickson JE, Hulbert ML, Jaroscak JJ, Kasow KA, Camacho-Bydume C, Ngwube A, Olson TS, Rangarajan HG, Horan JT, Krishnamurti L, Shenoy S, Abraham A, Nickel RS. Am J Hematol. 2026 Apr; 2026 Jan 12. PMID: 41524608.
• Reprogramming Stars #26: Understanding the Reprogramming Privilege-An Interview with Dr. Shangqin Guo.Guo S, Lopes M, Pereira CF. Cell Reprogram. 2026 Apr; 2025 Dec 17. PMID: 41467887.
• Global burden of lower respiratory infections and aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.Lancet Infect Dis. 2026 Apr; 2025 Dec 15. PMID: 41412141.
• 3D genetic architecture of schizophrenia risk across three neuronal subtypes.Powell SK, Liao W, Ghorbani S, Rigat R, O'Shea C, Kammourh S, Elahi R, Infante D, Deans PJM, Le DJ, Agarwal P, Qiang Seow W, Balafkan N, Wang KC, Akbarian S, Brennand KJ. Mol Psychiatry. 2026 Apr; 2025 Nov 28. PMID: 41310180.
• Tailoring Intensity: A Perspective on Thiotepa, Busulfan, and Fludarabine (TBF) Conditioning for Acute Leukemias and Myeloproliferative Neoplasms.Abdel Rahman Z, Mansour R, Kharfan-Dabaja M, Ma'koseh M, Muhanna Z, Saad A, Hanbali A, El Fakih R, Aljurf M. Transplant Cell Ther. 2026 Apr; 2025 Nov 8. PMID: 41213501.
• Host-transposon mutualism supports regeneration in planarians.Lee HL, Poulet A, Allikka Parambil S, van Wolfswinkel JC. Dev Cell. 2026 Mar 30; 2026 Mar 30. PMID: 41916287.
• Structure-Property-Function Relationships in Stimuli-Responsive Hydrogels for Brain Organoid Vascularization.Kim M, Choi H, Yang WS, Koh HJ. Gels. 2026 Mar 29; 2026 Mar 29. PMID: 42042125.
• Gene Therapy for Sickle Cell Disease: Practice Recommendations from the American Society for Transplantation and Cellular Therapy and the International Society for Cell & Gene Therapy.Sharma A, Kassim A, Thompson A, Williams DA, Liu HD, Boelens JJ, LaBelle JL, Tisdale J, de la Fuente J, Kanter J, Krishnamurti L, Pecker LH, Walters MC, Eapen M, Porteus M, Bhatia M, Soni S, Corbacioglu S, John TD, Cancio MI. Transplant Cell Ther. 2026 Mar 28; 2026 Mar 28. PMID: 41905703.
• Risk Factors for the Development of Avascular Necrosis Following Hematopoietic Cell Transplantation for Sickle Cell Disease.Hamidi R, Nallagatla VR, Liang J, Deng Y, Flagg A, Shah NC, Prior D, Krishnamurti L. Transplant Cell Ther. 2026 Mar 27; 2026 Mar 27. PMID: 41905705.
• Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic Leukemia.Lanino L, Hunter AM, Gagelmann N, Robin M, Dall'Olio D, Flamigni A, Sala C, Gurnari C, Wang YH, Pleyer L, Xicoy B, Montalban-Bravo G, Shih LY, Alsugair A, Fathima S, Gregorio C, Rollo C, Palomo L, Platzbecker AS, Asti G, Itzykson R, Sallman DA, Fariselli P, Kern W, Garcia-Manero G, Platzbecker U, Solé F, Diez-Campelo M, Maciejewski J, Bejar R, Thol F, Kroger N, Savona M, Fenaux P, Sanz G, Kordasti S, Santini V, Fontenay M, Zeidan AM, Komrokji RS, Haferlach T, Germing U, Castellani G, D'Amico S, Patnaik M, Ieva F, Solary E, Tefferi A, Padron E, Della Porta MG. J Clin Oncol. 2026 Mar 27; 2026 Mar 27. PMID: 41894646.
• Clonal Hematopoiesis Instructs Maladaptive Tissue Repair to Promote Fibrosis.Li D, Viñado AC, Garcia-Olloqui P, Montesi SB, Shea BS, Christian L, Vazquez-Urio I, Aguirre-Ruiz P, Ariceta B, Neubert M, Tripathy A, Barua N, Valera PS, Vera L, Petri E, Prasse A, Seeliger B, Vilas A, Martin PS, Calasanz MJ, Prosper F, Miller PG, Seeger W, Heidel FH, Schupp JC, Saez B, Pardo-Saganta A. bioRxiv. 2026 Mar 26; 2026 Mar 26. PMID: 41928940.
• Continuous intravenous infusion of human mesenchymal stromal cell-derived small extracellular vesicles in spinal cord injured rat modulates extracellular matrix and has greater therapeutic efficacy than multiple single injections.Nakazaki M, Lankford KL, Toyoshima M, Tanaka Y, Sumida TS, Kocsis JD. Neurotherapeutics. 2026 Mar 26; 2026 Mar 26. PMID: 41894999.
• Metabolic dysfunction-associated steatotic liver disease and acute leukemias - a literature review and future directions.Salah T, Stahl M, Bewersdorf JP. Leuk Lymphoma. 2026 Mar 25; 2026 Mar 25. PMID: 41879616.
• Pharmaco-behavioral profiling identifies suppressors of autism gene-associated phenotypes in zebrafish.Jamadagni P, Dai Y, Liu Y, Weinschutz Mendes H, Pruitt A, Khan S, Yang L, Huang TC, Huang X, Deans PJM, Balafkan N, Zhao D, Xu G, Liu Y, Li N, Wu W, Fitzpatrick SE, Neelakantan U, Chen T, Szialta C, Jin DS, Lacadie CM, Umlauf S, Papademetris X, Surovtseva YV, Brennand KJ, Wang Z, Hoffman EJ. Proc Natl Acad Sci U S A. 2026 Mar 24; 2026 Mar 16. PMID: 41838920.
• Glutamine metabolism tunes myeloid responses to drive resolution of inflammation during skin repair.Xu Y, Forni MF, Benvie A, Castano N, King D, Sun Q, Siebel S, Tran VA, Kibbey RG, Miller-Jensen K, Horsley V. Cell Rep. 2026 Mar 24; 2026 Feb 18. PMID: 41712383.
• Cannabidiol in Developmental Epilepsy: Organoid-Guided Precision Medicine Across Critical Neurodevelopmental Windows.Joo J, Yang WS, Koh HJ. Int J Mol Sci. 2026 Mar 23; 2026 Mar 23. PMID: 41898755.
• Tracheal Regeneration: Recent Progress in the Application of Stem Cells in Tracheal Bioengineering.Ganji F, Le Billan F, Haykal S, Karoubi G. Int J Mol Sci. 2026 Mar 23; 2026 Mar 23. PMID: 41898750.
• MASTR-seq enables multiplexed analysis of short tandem repeats with sequencing.Su C, Ryu HS, Chandradoss KR, Malachowski T, Boya R, Zhou L, Nguyen HE, Mazzoni EO, Brennand KJ, Phillips-Cremins JE. Cell Rep Methods. 2026 Mar 23; 2026 Mar 17. PMID: 41850290.
• Cardiovascular and Metabolic Outcomes in Adults with Fetal Alcohol Spectrum Disorders: A Retrospective Cohort Study.Weeks O, Sleeper LA, Khurshid S, Goessling W, Burns CG, Burns CE. medRxiv. 2026 Mar 22; 2026 Mar 22. PMID: 41891030.
• Establishing Area-Specific Brain Organoids Through Transcription Factor-Mediated Patterning.Kim J, Jang YS, Lee M, Choi NY, Jung Y, Lim J, Kwak TH. Biology (Basel). 2026 Mar 19; 2026 Mar 19. PMID: 41892247.
• Omics insights into MYBL2-promoted cancer stem-like cells driving ferroptosis resistance in hepatocellular carcinoma.Chen Y, Li X, Luo C, Lin G, Zhou X, Wen Z, Su H, Meng W, Chen C, Lu J, Luo X, Jiang D, Liu H, Ning Z, Chen Y, Tam PK, Pan X. J Adv Res. 2026 Mar 19; 2026 Mar 19. PMID: 41864611.
• Breast Tissue Reconstruction Strategies: A Tissue Engineering Approach.Stoian A, Duru Ç, Chogan F, Biniazan F, Temple B, Karoubi G, Haykal S. Tissue Eng Part B Rev. 2026 Mar 18; 2026 Mar 18. PMID: 40910925.
• A Deep Quantitative Proteome Turnover Platform for Human iPSC-derived Neurons.Frankenfield AM, Shih J, Zhang T, Ni J, Mazli WNAB, Lo E, Liu Y, Wang J, Hao L. bioRxiv. 2026 Mar 16; 2026 Mar 16. PMID: 41890021.
• A strong start for sustained success: inclusivity through a national group mentorship program for first-year graduate students.Labra SR, Tornini VA, Salazar MPR, Cossio DM, Gelpí RA, Perez BER, Rodríguez YM, Sandoval GL, Hernandez K, Goldman OV, Fernandez RW. bioRxiv. 2026 Mar 15; 2026 Mar 15. PMID: 41959524.
• Spatial profiling of patient-matched HER2 positive gastric cancer reveals resistance mechanisms to targeted therapy.Sheng T, Sundar R, Srivastava S, Ong X, Tay ST, Ma H, Uchihara T, Lian BSX, Hagihara T, Kong MS, Xu C, Ho SWT, Huang KK, Tan ALK, Ng MSW, Toh J, Ng CSY, Nasca V, Pircher CC, Randon G, Giordano S, Corso S, Lum JHY, Teh M, Zhao JJ, So JBY, Sabella G, Prabhakar S, Lee J, Yong WP, Ng MCH, Shitara K, Gasparello J, Fassan M, Pietrantonio F, Tan P. Gut. 2026 Mar 6; 2026 Mar 6. PMID: 41167802.
• Skin capillary endothelial cells form a network of spatiotemporally conserved Ca(2+) activity.Swaminathan A, Gonzalez DG, Matte-Martone C, Xu F, Simpson D, Moore JL, Lin Z, Rana U, Monedero-Alonso D, Mack JJ, Kam CY, Greco V. bioRxiv. 2026 Mar 6; 2026 Mar 6. PMID: 40894686.
• Gene-corrected regulatory T cell therapy for IL2RA deficiency.Ha AS, Kalter N, Rosenberg M, Acevedo LA, Liang B, Liu W, Paruthiyil S, Sinha M, Vu A, Nguyen V, Qi Z, Krishnappa N, Shu J, Yu J, Catanzaro J, Bluestone JA, Tang Q, Urnov FD, Marson A, Hendel A, Herold KC, Shy BR, Esensten JH. Mol Ther. 2026 Mar 4; 2025 Dec 9. PMID: 41376159.
• Haplotype editing with CRISPR-Cas9 as a therapeutic approach for dominant-negative missense mutations in NEFL.Dua PH, Simon BMJ, Marley CBE, Feliciano CM, Watry HL, Cowan QT, Steury D, Abraham A, Gilbertson EN, Ramey GD, Capra JA, Conklin BR, Judge LM. Mol Ther. 2026 Mar 4; 2025 Nov 19. PMID: 41267399.
• Intranasal administration of human mesenchymal stromal cell-derived small extracellular vesicles delays disease progression in the SOD1(G93A) mouse model.Hirota R, Lankford KL, Nakazaki M, Toyoshima M, Kocsis JD. Mol Brain. 2026 Mar 3; 2026 Mar 3. PMID: 41776544.
• Global burden of adverse effects of medical treatment from 1990 to 2021: a Global Burden of Disease Study 2021.Korean J Intern Med. 2026 Mar; 2026 Mar 1. PMID: 41850226.
• Global, regional, and national burden of breast cancer among females, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023.Lancet Oncol. 2026 Mar. PMID: 41785894.
• Piezo1-dependent activation of stromal cells ignites muscle inflammation in exercise and injury and is associated with inflammaging.Langston PK, Vijaya Raghavan J, Benoist C, Mathis D. Nat Immunol. 2026 Mar; 2026 Mar 3. PMID: 41775886.
• Concurrent pulmonary aspergillosis and phaeohyphomycosis due to Verruconis spp. in a stem cell transplant recipient with chronic graft-versus-host disease.Carreras X, Machiavello Roman F. Med Mycol Case Rep. 2026 Mar; 2026 Jan 16. PMID: 41624956.
• tRNA m(1)A modification orchestrates STING translation in macrophages to enhance antitumor immunity and CAR-macrophage immunotherapy.Wang X, Wang X, Li H, Liu S, Lu Y, Chen H, Cai X, Su S, Li B, Liu R, Hu W, Zhu X, Zhang J, Ye Y, Li HB. Cell Mol Immunol. 2026 Mar; 2026 Jan 14. PMID: 41535541.
• IDR-induced CAR condensation improves the cytotoxicity of CAR-Ts against low-antigen cancers.Zhang X, Xiao Q, Zeng L, Hashmi F, Sato K, Hartwich TMP, Mansolf M, Yang-Hartwich Y, Su X. Nat Chem Biol. 2026 Mar; 2025 Sep 29. PMID: 41023404.
• A modular vaccine platform for optimized lipid nanoparticle mRNA immunogenicity.Fang Z, Monteiro VS, Oh C, Janabi KA, Romero L, Ahsan N, Yang L, Peng L, DiMaio D, Lucas C, Chen S. Nat Biomed Eng. 2026 Mar; 2025 Aug 25. PMID: 40855125.
• Mast cell extracellular granules are bioactive condensates assembled by heparin and polyamine.Xiong Y, Tomares DT, Guo J, Sato K, Zeng L, Tian Y, Su M, Albis A, Pant A, Pappu RV, Su X. Nat Chem Biol. 2026 Feb 27; 2026 Feb 27. PMID: 41760814.
• No clear benefit of cellular therapy consolidation for patients achieving remission after post-HCT AML relapse.Murdock HM, Kim HT, Maurer K, Kelkar A, Shapiro RM, Gooptu M, Romee R, Nageshwar PK, Garrity HM, Shimony S, Luskin MR, Winer ES, Vedula RS, Stahl M, Chen EC, Volpe V, Garcia JS, Wadleigh M, DeAngelo DJ, Stone RM, Wu CJ, Cutler CS, Koreth J, Ritz J, Antin JH, Ho VT, Nikiforow S, Soiffer RJ. Blood Adv. 2026 Feb 24. PMID: 41172235.
• Non-invasive ovulation tracking enables genetic engineering in wild rodents.Buchthal J, Chory EJ, Hill Z, Dennison C, Tu B, Wierenga RP, Çevrim Ç, Golas S, Meier G, Lan TCT, Chung H, Boucher M, Telford SR, McKinley KL, Markoulaki S, Jaenisch R, Esvelt KM. Cell Rep Methods. 2026 Feb 23; 2026 Feb 17. PMID: 41709464.
• Thorn specification in citrus plants by an SHI/STY family transcription factor.Zheng Q, Zhou S, Irish VF, Zhang F. Curr Biol. 2026 Feb 23; 2026 Feb 2. PMID: 41633363.
• Estradiol modulates neuronal network hyperexcitability in select NDD risk genes.Pruitt A, Yang L, Lee S, Balafkan N, Seah C, Dai Y, Davidson E, Khan S, Sen A, Liu J, Wood I, Xu G, Huang X, Carlson M, Zhao D, Jamadagni P, Dossou G, Retallick-Townsley K, Li X, Deans PJM, Garcia MF, Gao H, Wang Z, Huckins LM, Hoffman EJ, Brennand KJ. bioRxiv. 2026 Feb 18; 2026 Feb 18. PMID: 41757108.
• Rethinking the microenvironment's role in chemical-induced malignancy.Bisson WH, Currie RA, Lim EL, Mlynarczyk C, Tokar EJ, Colacci A, Colacino JA. Toxicol Sci. 2026 Feb 18. PMID: 41405843.
• Hormonal control of postmitotic neuronal identity.Wani AR, Ashraf R, Woerner R, Marriner Z, Velasquez M, Azam T, Joo Q, Dus M, Syed MH. bioRxiv. 2026 Feb 13; 2026 Feb 13. PMID: 41659434.
• Early time to relapse as a survival prognosticator in nodal mature T-cell lymphomas: results from the PETAL consortium.Sorial MN, Malpica Castillo LE, Chiattone C, Julia E, Bachy E, Barta SK, Stuver R, Jacobsen E, Federico M, Jain H, Prince HM, Foss F, Zinzani PL, Okatani T, Kim WS, Verburgh E, Al-Mansour M, Cabrera ME, Bhagat G, Shen C, Jain S. Blood. 2026 Feb 12. PMID: 41347825.
• Informed shared decision-making or rigid eligibility and exclusion criteria for gene therapy for sickle cell disease?Krishnamurti L, Olafimihan A, Hsu LL. Blood Adv. 2026 Feb 10. PMID: 41092461.
• Therapeutic Potential of Extracellular Vesicles: From Biogenesis, Isolation and Molecular Characterization to Addressing Translational Gaps and Regulatory Barriers.Primorac D, Brlek P, Bulić L, Hrvatin N, Škaro V, Projić P, Glavan M, Oleru I, Rocheteau P, Tremolada C, DeMers A, Ambach MA, Buford D, Knežević T, Kouroupis D, Conforti C, Kimbrough DW, Schnorr RP, Williams L, Vaiciuleviciute R, Fortuna Ž, Oprešnik L, Curk B, Knežević M, Kalan Živčec G, Hrkać A, Tsoukas D, Uzieliene I, Pachaleva J, Bernotiene E, Barbato K, Patel N, Guanche ID, Badiavas EV, Mešić J, Medić Flajšman A, Milanič R, Klarić D, Kalodimou VE, Allegri M, Brachmann J, Toh WS, Delgado ND, Mobasheri A. Int J Mol Sci. 2026 Feb 9; 2026 Feb 9. PMID: 41751812.
• Single-cell Spatial Multiomics: Technologies, Methods, and Biological Applications.Xing D, Fan R, Zhao F. Genomics Proteomics Bioinformatics. 2026 Feb 9; 2026 Feb 9. PMID: 41660845.
• Disseminated mucormycosis.Radcliffe CV, Tremblay EE, Machiavello Roman FJ. IDCases. 2026; 2026 Feb 7. PMID: 41717056.
• Biochemical Reconstitution and FRAP Analysis of Membrane-Associated Condensates on Supported Lipid Bilayers.Zeng L, Su X. Bio Protoc. 2026 Feb 5; 2026 Feb 5. PMID: 41675989.
• Mechanical Stretch Disrupts Calcium Dynamics and Redistributes Piezo1 in Human Astrocytes.Shiravi S, Chakka A, Xiao X, Garcia MF, Yufa A, Mitevska A, Seah C, Gao H, Huckins LM, Brennand KJ, Finan JD. Ann Biomed Eng. 2026 Feb 5; 2026 Feb 5. PMID: 41642456.
• Modelling chemotaxis of branched cells in complex environments provides insights into immune cell navigation.Liu J, Ron JE, Rinaldi G, Williantarra I, Georgantzoglou A, Vries I, Sixt M, Sarris M, Gov NS. PLoS Comput Biol. 2026 Feb; 2026 Feb 3. PMID: 41632822.
• Training Tomorrow's Leaders in Cancer Immunology.Tan Y, Kim BJ, Mujal AM, Chen ACY, Weis AM, Bergaggio E, Micevic G, Xie H, Park JS, Hor JL, Papanicolaou M, Shobaki N, Domizi P, Delconte RB, Vendramin R, Hegde S, Han S, Su Y, Hacohen N. Cancer Immunol Res. 2026 Feb 3. PMID: 41524276.
• Comparison of Outcomes With Novel Versus Traditional Chemotherapy Regimens for Relapsed and Refractory Classical Hodgkin Lymphoma.Ermann D, Vardell V, Zacholski E, Fegley A, Modi D, Fedak K, Sundaram S, Rajeeve S, Goyal G, Hatic H, Torka P, Ba Aqeel S, Borogovac A, MacDougall K, Kothari S, Kress A, Travers E, Chilakamarri N, Brem E, Ayyappan S, Sigmund A, Bond D, Fitzgerald L, Wagner C, Hu B, Stephens DM, Shah H. Clin Lymphoma Myeloma Leuk. 2026 Feb 2; 2026 Feb 2. PMID: 41763973.